A detailed history of Biltmore Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Biltmore Wealth Management, LLC holds 246 shares of LLY stock, worth $185,730. This represents 0.09% of its overall portfolio holdings.

Number of Shares
246
Previous 241 2.07%
Holding current value
$185,730
Previous $218,000 0.46%
% of portfolio
0.09%
Previous 0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$772.14 - $960.02 $3,860 - $4,800
5 Added 2.07%
246 $217,000
Q2 2024

Jul 12, 2024

BUY
$724.87 - $909.04 $174,693 - $219,078
241 New
241 $218,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Biltmore Wealth Management, LLC Portfolio

Follow Biltmore Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Biltmore Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biltmore Wealth Management, LLC with notifications on news.